Kura Oncology Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | -147.7% | |
| – | +666,566.7% | +55.0% | -3.2% | -66.7% | -11,130.0% | – | +187.6% | +36.0% | +11.9% | -0.1% | -979.2% | |
| – | +317,621.5% | -7.5% | +117.6% | +90.4% | +8.7% | +36.1% | +84.1% | +11.6% | +6.7% | +20.7% | +9.5% | |
| – | +48.2% | -31.0% | +94.8% | +107.9% | +2.8% | +36.1% | +88.9% | +9.1% | – | – | – | |
| – | +41,805.6% | -105.7% | – | +71.1% | -98.3% | +8,527.0% | -150.5% | – | – | +3,560.0% | -35.5% | |
| – | +76,090.5% | -100.0% | – | +0.0% | +0.0% | +0.0% | -47.2% | -45.4% | -73.2% | +181.0% | +1,306.4% | |
| – | +84,078,471.4% | – | -292.3% | +238.6% | -41.6% | +115.7% | +26.9% | – | -52.3% | -753.0% | -87.1% | |
| – | +9,786,900.0% | -44.9% | +0.0% | +145.2% | -18.2% | +324.7% | – | – | – | – | – | |
| – | +33,233.3% | +49.1% | -108.4% | +0.0% | -59.9% | +0.0% | +3,044.4% | – | -100.0% | – | – | |
| – | +1,713,543.2% | -92.8% | +618.7% | +147.6% | -16.2% | +322.4% | -100.7% | – | +145.8% | +62.9% | -98.8% | |
| – | +1,181.4% | -139.9% | – | +174.4% | +113.7% | +2,890.9% | -178.4% | – | – | – | -140.3% | |
| – | – | – | – | – | – | – | – | – | – | – | -152.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.